Picture of Puma Biotechnology logo

PBYI — Puma Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Puma Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

* Puma Biotechnology Inc  PBYI.OQ  reported a quarterly
adjusted
loss of 9 cents​​ per share for the quarter ended in June, lower
than the same quarter last year, when the company reported EPS
of 5 cents.  The mean expectation of three analysts for the
quarter was for a loss of 13 cents per share. Wall Street
expected results to range from -19 cents to -8 cents per share.
    * Revenue fell 13.7% to $47.10 million from a year ago;
analysts
expected $44.70 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
a loss
of 9 cents​.
    * The company reported a quarterly loss of $4.5 million.
    * Puma Biotechnology Inc shares had risen by 10.0% this
quarter and lost 17.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 30.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.00 
This summary was machine generated from LSEG data August 2 at
02:06 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.13          -0.09          Beat
 Mar. 31 2024      -0.22          -0.10          Beat
 Dec. 31 2023      0.30           0.26           Missed
 Sep. 30 2023      0.08           0.12           Beat

Recent news on Puma Biotechnology

See all news